Manufacturing, Expression Systems

MilliporeSigma Adds Viral Vector and Gene Therapy Capacity

April 21, 2020

The company will build an additional commercial-scale, contract manufacturing facility for viral vectors and gene therapies near its existing site in Carlsbad, CA.

Absolute Antibody Launches New, High-Throughput Recombinant Antibody Production Service

March 05, 2020

The technology enables the rapid production of large numbers of recombinant antibodies at 80-mL scale.

Flexible Facilities for Viral Vector Manufacturing

March 02, 2020

BioPharm International

Single-use and modular systems will meet demand for rapid implementation at different scales.

Dyadic Achieves G2 Human-Like Glycosylation Milestone

February 27, 2020

The company presented data on its G2 glycosylation studies at the 15th European Conference on Fungal Genetics in Rome on Feb. 19, 2020.

GE Healthcare Launches Viral Vector-Based Gene Therapy Manufacturing

October 28, 2019

GE Healthcare Life Sciences’ KUBio box is an integrated, flexible biomanufacturing environment for viral vector-based gene therapies.

Turning to Plant Cell Culture for Sustainability

September 01, 2019

BioPharm International

In an effort to secure a continuous, sustainable supply of an important vaccine ingredient, Agenus is turning to a plant cell-based cell culture method for production.

Seeking Solutions for Large-Scale GMP Viral Vector Manufacturing

September 01, 2019

BioPharm International

Innovation in manufacturing technologies must occur to ensure the availability of gene and cell therapies.

Cell-Culture Advances Test Bioreactor Performance Models

September 01, 2019

BioPharm International

The evolution of cell-culture technology is driving the need for improvements in modeling solutions.

Streamlining Upstream Processing: A Good Place to Start

June 01, 2019

BioPharm International

As cost and time pressures within biopharma are on the rise, innovative expression systems may offer companies a good opportunity to streamline processes early on.

G-CON Manufacturing and GE Healthcare Collaborate to Advance Early-Stage Cell Therapy and Viral Vector Manufacturing

January 25, 2019

G-CON will provide a complete cleanroom infrastructure for GE Healthcare’s cell therapy and viral vector production platforms that will simplify early-stage manufacturing efforts.